Biomarkers and testing in pathology

Although pathology is still the gold standard in diagnosis of tumor for patients in uropathology, many clinicians want to improve treatment options and try to tailor personalized treatments. This is of course depending not only on the available treatment options, but also on the somatic or germcell background of the patient and his tumor.

Authors

Institutions

Publication Details

Journal
Current Opinion in Urology
Published
2026-01-08
DOI
https://doi.org/10.1097/mou.0000000000001363
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomarkers and testing in pathology

Eva Compérat
Current Opinion in Urology
Bladder and Urothelial Cancer Treatments
article

Biomarkers and testing in pathology

Eva Compérat
article en

Abstract

Although pathology is still the gold standard in diagnosis of tumor for patients in uropathology, many clinicians want to improve treatment options and try to tailor personalized treatments. This is of course depending not only on the available treatment options, but also on the somatic or germcell background of the patient and his tumor.

Current Opinion in UrologyVol. 36(2)
Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 93%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biomarkers and testing in pathology — Eva Compérat · Current Opinion in Urology (2026) | TGRS Research Map | TGRS